Clinical Trials Logo

Clinical Trial Summary

Can oral midazolam used for sedation in patients undergoing upper gastrointestinal endoscopy ?


Clinical Trial Description

Five mg of midazolam was intake orally about 30 minutes before undergoing perform upper gastrointestinal endoscopy. Declined of anxiety scores was primary end point. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Conscious Sedation Failure During Procedure

NCT number NCT01990937
Study type Interventional
Source Phramongkutklao College of Medicine and Hospital
Contact Chaipichit Puttapitakpong, Doctor
Phone 6681707-3005
Email iamkeang@hotmail.com
Status Recruiting
Phase Phase 4
Start date October 2013
Completion date February 2015

See also
  Status Clinical Trial Phase
Completed NCT02512055 - Ketamine Tolerance in Children After Repeated Administrations During Radiotherapy Sessions Phase 4
Completed NCT05115578 - Remifentanil Effect-site Prediction by Algometry
Completed NCT00902395 - Efficacy of Moderate Sedation for Dental Treatment of Young Children Phase 4
Recruiting NCT04997967 - Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis Phase 4
Completed NCT02676206 - Music Therapy in Procedural Sedation in the Emergency Department N/A
Completed NCT02820051 - Non-anesthesiologist-administered Propofol During the Flexible Bronchoscopy N/A
Recruiting NCT02205502 - Lidocaine as Local Anesthetics in Children Under Ketamine Sedation Phase 4
Completed NCT00596050 - Ketamine Versus Etomidate for Procedural Sedation for Pediatric Orthopedic Reductions Phase 4
Unknown status NCT01321047 - Balanced Propofol Sedation Versus Propofol Alone Sedation in Therapeutic Endoscopic Retrograde Cholangiopancreatography (ERCP) Phase 4